$BLPH - Bellerophon Reports Positive Top-Line Data from Phase 2 Acute Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Sarcoidosis: https://finance.yahoo.com/news/bellerophon-reports-positive-top-line-133000983.html?guccounter=1&guce_referrer=aHR0cHM6Ly9maW52aXouY29tLw&guce_referrer_sig=AQAAAFmxB_BFiiwd9GE00Y25A0ruvh6lb72ImtpTmJVcQuikwNkZgGmRkjHzlnfWzObnm1me8rs3om3m7dv2J3CJJfIAtYEqDEzkW1PpcqbLzrdKyJebShSM9gwxXScR8HoWmhef2hXbAKCLgvMbIW6GjGsbi_DSiRHvQVMgeDdhYlmS
$SPRB - Spruce Biosciences Rallies on Oppenheimer Outperform Rating: https://finance.yahoo.com/news/spruce-biosciences-rallies-oppenheimer-outperform-121612635.html